- Market Realist•yesterday
Since June 2015, Teva Pharmaceutical has traded at discount valuations compared to Novartis and Pfizer but at premium valuations compared to Mylan.
- Investor's Business Daily•yesterday
Amgen and Biogen could square off to acquire muscle biologist Cytokinetics, while many players look at Adamas Pharmaceuticals.
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||50.94 x 100|
|Ask||51.95 x 100|
|Day's Range||50.85 - 51.51|
|52wk Range||48.01 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.38|
|Avg Vol (3m)||5,764,806|
|Dividend & Yield||1.36 (2.64%)|